http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113234760-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-10022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-10034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10043 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70521 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-861 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 |
| filingDate | 2021-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113234760-B |
| titleOfInvention | Recombinant type 5 adenovirus vector containing porcine reproductive and respiratory syndrome ORF5 gene and its preparation method and application |
| abstract | The invention relates to the field of biotechnology, in particular to a recombinant type 5 adenovirus vector containing porcine reproductive and respiratory syndrome ORF5 gene and its preparation method and application. The invention comprises a recombinant type 5 adenovirus vector containing porcine reproductive and respiratory syndrome virus ORF5 gene, and co-expresses porcine reproductive and respiratory syndrome virus ORF5 gene and porcine CTLA4 gene. Tests have shown that the recombinant adenoviral vector rAd‑CTLA4‑ORF5 fused with the CTLA4 gene only needs one injection to stimulate the body to produce specific humoral and cellular immune responses, just like two immunizations with imported vaccines. The recombinant adenovirus vector rAd-CTLA4-ORF5 of the present invention can be used as a vaccine or medicine for preventing and treating reproductive and respiratory syndrome virus. |
| priorityDate | 2021-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 106.